Adel Nada
Chief Executive Officer at GentiBio, Inc.
Adel Nada active positions
| Companies | Position | Start | End |
|---|---|---|---|
GentiBio, Inc.
 GentiBio, Inc. BiotechnologyHealth Technology GentiBio, Inc. engages in the development of engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory, and allergic diseases. The company was founded by Adel Nada, David Rawlings, Jane H. Buckner, and Gideon Gross and is headquartered in Seattle, WA. | Chief Executive Officer | - | - |
| Founder | - | - | |
| President | - | - | |
Alia Therapeutics Srl
 Alia Therapeutics Srl BiotechnologyHealth Technology Alia Therapeutics Srl engages in experimental research activities in the field of biotechnology. It specializes in the identification of new technologies for genome modification. The company was founded by Gianluca Petris, Antonio Casini, and Anna Cereseto and is headquartered in Trento, Italy. | Director/Board Member | 2023-05-08 | - |
| Independent Dir/Board Member | 2023-05-08 | - |
Career history of Adel Nada
Former positions of Adel Nada
| Companies | Position | Start | End |
|---|---|---|---|
Caladrius Biosciences, Inc.
 Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Corporate Officer/Principal | 2014-04-10 | - |
Training of Adel Nada
| Alexandria University | Doctorate Degree |
| Rush University | Graduate Degree |
Statistics
International
| United States | 4 |
| 2 | |
| Italy | 2 |
Operational
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Health Technology |
GentiBio, Inc.
GentiBio, Inc. BiotechnologyHealth Technology GentiBio, Inc. engages in the development of engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory, and allergic diseases. The company was founded by Adel Nada, David Rawlings, Jane H. Buckner, and Gideon Gross and is headquartered in Seattle, WA. | Health Technology |
Alia Therapeutics Srl
Alia Therapeutics Srl BiotechnologyHealth Technology Alia Therapeutics Srl engages in experimental research activities in the field of biotechnology. It specializes in the identification of new technologies for genome modification. The company was founded by Gianluca Petris, Antonio Casini, and Anna Cereseto and is headquartered in Trento, Italy. | Health Technology |
- Stock Market
- Insiders
- Adel Nada
- Experience
